Zenas BioPharma Appoints Lisa von Moltke, M.D., as Head of Research and Development and Chief Medical Officer
Dr. von Moltke brings over 30 years of deep drug development experience and a proven track record of clinical and regulatory success at both ...
Curevo Raises $110 Million to Advance Amezosvatein Shingles Vaccine
Amezosvatein has shown excellent immunogenicity and improved tolerability in Phase 2 study -- Medicxi leads round, joined by new investors ...
STAT17h
Small vaccine maker names Operation Warp Speed leader as chairman, raises $110 million
Moncef Slaoui, who ran the Operation Warp Speed Covid vaccine effort, is becoming chair of Curevo, a company developing a new ...
Latigo Biotherapeutics Closes $150 Million in Series B Financing to Advance Non-Opioid Pain Therapeutics
Latigo Biotherapeutics ("Latigo"), a clinical-stage biotechnology company developing best-in-class non-opioid pain treatments ...
Oncology Market Assessment: Strategic Insights for Investment or Divestment | DelveInsight
A global pharmaceutical company, having recently acquired a mid-cap biotech firm, sought to evaluate the market value of a ...
Packaging World7h
Snuggle’s Packaging Rebrand Emphasizes Visual, Value Recognition
Snuggle has redesigned its look for its fabric softener, dryer sheets, and scent booster crystals, the company announced. The ...
DelveInsight Business Research, LLP: Oncology Market Assessment: Strategic Insights for Investment or Divestment | DelveInsight
The oncology therapy landscape is rapidly evolving, with immune checkpoint inhibitors reshaping cancer treatment by leveraging the body's own immune system to combat tumors. As the immune checkpoint ...
The New York Times12h
New York Times - Top Stories
With Arrival of Bongino, Trump Loyalists Take Command of the F.B.I. From his wildly popular podcast to the No. 2 post at the F.B.I., Dan Bongino joins Kash Patel to lead the agency at a turning ...